Drug Price Trends for FT NIGHT SEVERE COLD-FLU LIQ

Average Pharmacy Cost for FT NIGHT SEVERE COLD-FLU LIQ

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FT NIGHT SEVERE COLD-FLU LIQ	70677-1030-01	0.01290	ML	2025-12-17
FT NIGHT SEVERE COLD-FLU LIQ	70677-1030-01	0.01290	ML	2025-11-19
FT NIGHT SEVERE COLD-FLU LIQ	70677-1030-01	0.01290	ML	2025-10-22
FT NIGHT SEVERE COLD-FLU LIQ	70677-1030-01	0.01290	ML	2025-09-17
FT NIGHT SEVERE COLD-FLU LIQ	70677-1030-01	0.01290	ML	2025-08-20
FT NIGHT SEVERE COLD-FLU LIQ	70677-1030-01	0.01290	ML	2025-07-23
FT NIGHT SEVERE COLD-FLU LIQ	70677-1030-01	0.01290	ML	2025-06-18

Market Analysis and Price Projections for FT NIGHT SEVERE COLD-FLU LIQ

Last updated: February 20, 2026

What is the current market landscape for cold and flu remedies?

FT NIGHT SEVERE COLD-FLU LIQ is positioned within the over-the-counter (OTC) cold and flu medication market, which has experienced consistent growth driven by seasonal demand, aging populations, and increasing consumer preference for self-care. The global cold and flu medication market was valued at approximately $15 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 4.5% projected through 2028 [1].

Key competitors include products such as NyQuil, DayQuil, Theraflu, and store-brand equivalents. These brands dominate shelf space in major retail outlets and pharmacy chains in North America and Europe.

What are the primary factors influencing growth and pricing?

Demand drivers

• Seasonality: Peak sales from late fall to early spring.
• Aging Population: Older adults exhibit higher susceptibility to cold and flu, increasing demand.
• Self-care Preference: Consumers favor OTC options over prescribed medications.

Supply factors

• Manufacturing capacity: Production scale affects availability and pricing.
• Regulatory environment: Approvals and labeling influence market entry and competitiveness.
• Material costs: Ingredient prices, especially active pharmaceutical ingredients (APIs), impact margins.

Pricing strategies

• Retail prices for similar adult OTC cold and flu liquids range from $7 to $12 per 8- to 12-ounce bottle.
• Brand-name products like NyQuil typically command higher prices ($10–$12), while store brands sell at lower prices ($7–$9).
• Pricing reflects formulation complexity, marketing, and perceived brand trust.

What are the current price projections?

Short-term (1–2 years)

• Retail price for FT NIGHT SEVERE COLD-FLU LIQ is expected to remain within the $8–$10 range, assuming standard production costs and no major supply chain disruptions.
• Competitive pricing may pressure margins; potential introduction of value variants could lower average selling prices.

Medium to long-term (3–5 years)

• Slight price increases of 2–3% annually are projected due to inflation, ingredient costs, and regulatory compliance.
• Market consolidation or patent protections could enable premium pricing for differentiated formulations.
• Market expansion into emerging markets may lead to lower prices initially but could support substantial volume growth.

Influence of market dynamics

• The rise in consumer demand for natural and organic alternatives poses a risk to traditional formulations, potentially affecting prices.
• The entry of generic versions or store-brand competitors could further compress prices.
• OTC regulations evolving in different jurisdictions may impact permissible pricing strategies.

What strategic considerations should stakeholders evaluate?

• Investment in product differentiation, such as flavor or ingredient improvements, can justify premium pricing.
• Monitoring supply chain costs, particularly API availability, is critical.
• Marketing efforts should target seasonal peaks and demographic segments with higher usage rates.

Summary table of key projections

Time Frame	Projected Retail Price Range	Key Influencing Factors
1–2 Years	$8–$10	Supply stability, competitive pricing, seasonal peak
3–5 Years	$8.16–$10.30	Inflation, market expansion, formulation differentiation

Key Takeaways

• The OTC cold and flu liquid market is mature with steady growth driven by seasonality and demographic shifts.
• FT NIGHT SEVERE COLD-FLU LIQ is likely to be priced similarly to competitors, with prices in the $8–$10 range.
• Price increases will stay modest, affected mainly by inflation, formulation improvements, and regulatory changes.
• Market pressures include brand competition, generics, and evolving consumer preferences toward natural products.
• Strategic differentiation and cost management are key for maintaining margins.

FAQs

1. How does weather influence the market for cold and flu liquids?
   Cold and flu medication sales peak during colder months, specifically late fall and winter, due to higher incidence of illnesses.

2. What impact does regulatory change have on pricing?
   Stricter regulations can increase manufacturing costs or restrict certain formulations, leading to higher retail prices or product reformulation.

3. Are herbal or natural variants affecting traditional cold and flu product prices?
   Yes. The increasing demand for natural remedies has pressured prices of conventional OTC medications downward, particularly in segments targeting health-conscious consumers.

4. How do supply chain disruptions affect prices?
   Shortages of key ingredients or packaging materials can reduce supply, causing price increases or temporary product shortages.

5. What role does consumer perception play in pricing strategy?
   Brand trust and perceived efficacy influence willingness to pay premium prices, enabling brands to maintain higher retail points.

References

[1] MarketsandMarkets. (2022). Cold and Flu Medication Market by Product, Distribution Channel, and Region.